Halozyme Therapeutics
Dan Rezac is a Principal Manufacturing Engineer at Halozyme, Inc. since May 2022, specializing in the writing and execution of IQ/OQ/PQ protocols and risk evaluation through PFMEA. Previously, Dan served as a Senior Manufacturing Engineer at Antares Pharma Inc., contributing to the transition of the company upon its acquisition by Halozyme. Extensive experience includes roles as Lead Manufacturing Engineer at SUEZ - Water Technologies & Solutions and GE Power & Water, focusing on capital project management, process improvement, and machine design. Earlier positions involved continuous improvement and process engineering at BIC Graphic USA and Daktronics. Dan holds a Master's Degree in Operations Management and a Bachelor's Degree in Manufacturing Engineering from South Dakota State University, complemented by a study abroad program in German Studies at the University of Stuttgart.
This person is not in any offices
Halozyme Therapeutics
7 followers
Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies.